Polymorphism in glutathione S-transferases: Susceptibility and treatment outcome for head and neck cancer

Xenobiotica

Volumn 41, Issue 12, 2011, Pages 1122-1130

  Ruwali, Munindra ^a   Singh, Madhu ^a   Pant, Mohan C ^b   Parmar, Devendra ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Alcohol; Larynx; Oral cavity; Pharynx; Tobacco

Indexed keywords

CISPLATIN; FLUOROURACIL; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PHARYNX CANCER; TREATMENT OUTCOME; TREATMENT RESPONSE;

ALCOHOL DRINKING; CASE-CONTROL STUDIES; DEMOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SMOKING; TOBACCO, SMOKELESS; TREATMENT OUTCOME;

NICOTIANA TABACUM;

EID: 80655145980     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2011.614020     Document Type: Article

References (53)

1. Anantharaman D, Chaubal PM, Kannan S, Bhisey RA, Mahimkar MB. (2007). Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator. Carcinogenesis 28:1455-1462. (Pubitemid 47241795)
2. Arand M, Mühlbauer R, Hengstler J, Jäger E, Fuchs J, Winkler L, Oesch F. (1996). A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal Biochem 236:184-186. (Pubitemid 26100747)
3. Brennan P, Bofetta P. (2004). Mechanistic considerations in the molecular epidemiology of head and neck cancer. IARC Sci Publ 157:393-414.
4. Buch SC, Notani PN, Bhisey RA. (2002). Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis 23:803-807. (Pubitemid 34567519)
5. Cabelguenne A, Loriot MA, Stucker I, Blons H, Koum-Besson E, Brasnu D, Beaune P, Laccourreye O, Laurent-Puig P, De Waziers I. (2001). Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapy. Int J Cancer 93:725-730. (Pubitemid 32695124)
6. Cho CG, Lee SK, Nam SY, Lee MS, Lee SW, Choi EK, Park HJ, Kim SY. (2006). Association of the GSTP1 and NQO1 polymorphisms and head and neck squamous cell carcinoma risk. J Korean Med Sci 21:1075-1079.
7. Eaton DL, Bammler TK. (1999). Concise review of the glutathione S-transferases and their signifcance to toxicology. Toxicol Sci 49:156-164. (Pubitemid 29300401)
8. Eferth T, Volm M. (2005). Pharmacogenetics for individualized cancer chemotherapy. Pharmacol Ter 107:155-176. (Pubitemid 40910039)
9. Farin FM, Bigler LG, Oda D, McDougall JK, Omiecinski CJ. (1995). Expression of cytochrome P450 and microsomal exposide hydrolase in cervical and oral epithelial cells immortalized by human papillomavirus type 16 E6/E7 genes. Carcinogenesis 16:1670.
10. Geisler SA, Olshan AF. (2001). GSTM1, GSTT1, and the risk of squamous cell carcinoma of the head and neck: A mini-HuGE review. Am J Epidemiol 154:95-105. (Pubitemid 32643123)
11. Goto S, Iida T, Cho S, Oka M, Kohno S, Kondo T. (1999). Overexpression of glutathione S-transferase pi enhances the adduct formation of cisplatin with glutathione in human cancer cells. Free Radic Res 31:549-558.
12. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. (1997). Identifcation of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 18:641-644. (Pubitemid 28132446)
13. Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wünsch-Filho V, Franceschi S, Hayes RB, Herrero R, Koifman S, La Vecchia C, Lazarus P, Levi F, Mates D, Matos E, Menezes A, Muscat J, Eluf-Neto J, Olshan A F, Rudnai P, Schwartz SM, Smith E, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, Wei Q, Winn DM, Zaridze D, Zatonski W, Zhang ZF, Berthiller J, Bofetta P. (2007). Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 99:777-789. (Pubitemid 47073524)
14. Hashibe M, Brennan P, Strange RC, Bhisey R, Cascorbi I, Lazarus P, Oude Ophuis MB, Benhamou S, Foulkes WD, Katoh T, Coutelle C, Romkes M, Gaspari L, Taioli E, Bofetta P. (2003). Meta-and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 12:1509-1517. (Pubitemid 38031756)
15. Hayes JD, Pickett CB, Mantle TJ. (1990). Gluthathione S-transferase and drug resistance. London: Taylor and Francis.
16. Hayes JD, Pulford DJ. (1995). Te glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 30:445-600.
17. Hiyama T, Yoshihara M, Tanaka S, Chayama K. (2008). Genetic polymorphisms and head and neck cancer risk (Review). Int J Oncol 32:945-973.
18. Howie NM, Trigkas TK, Cruchley AT, Wertz PW, Squier CA, Williams DM. (2001). Short-term exposure to alcohol increases the permeability of human oral mucosa. Oral Dis 7:349-354. (Pubitemid 34072452)
19. Hu X, Xia H, Srivastava SK, Herzog C, Awasthi YC, Ji X, Zimniak P, Singh SV. (1997). Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun 238:397-402. (Pubitemid 27464396)
20. Hung HC, Chuang J, Chien YC, Chern HD, Chiang CP, Kuo YS, Hildesheim A, Chen CJ. (1997). Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 6:901-905. (Pubitemid 27481638)
21. Jhavar S, Sarin R, Mulherkar R, Benner A, Agarwal JP, Dinshaw K. (2004). Glutathione S-transferase M1 or T1 null genotype as a risk factor for developing multiple primary neoplasms in the upper aero-digestive tract, in Indian males using tobacco. Oral Oncol 40:84-91. (Pubitemid 37510217)
22. Jourenkova-Mironova N, Rainikainen M, Bouchardy C, Benhamou PS, Hirvonen A. (1998). Larynx cancer risk in relation to glutathione-Stransferase M1 & T1 genotypes and tobacco smoking. Cancer Epidem Biomarkers Prev 7:19-23. (Pubitemid 28087137)
23. Jourenkova-Mironova N, Voho A, Bouchardy C, Wikman H, Dayer P, Benhamou S, Hirvonen A. (1999). Glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes and the risk of smoking-related oral and pharyngeal cancers. Int J Cancer 81:44-48. (Pubitemid 29124195)
24. Katoh T, Kaneko S, Kohshi K, Munaka M, Kitagawa K, Kunugita N, Ikemura K, Kawamoto T. (1999). Genetic polymorphisms of tobacco-and alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer 83:606-609. (Pubitemid 29508037)
25. Kihara M, Kihara M, Kubota A, Furukawa M, Kimura H. (1997). GSTM1 gene polymorphism as a possible marker for susceptibility to head and neck cancers among Japanese smokers. Cancer Lett 112:257-262. (Pubitemid 27104304)
26. Lafuente A, Maristany M, Arias C, Cuchi A, Lafuente MJ, Molina R, Ballesta A, Trasserra J. (1998). Glutathione and glutathione S-transferases in human squamous cell carcinomas of the larynx and GSTM1 dependent risk. Anticancer Res 18:107-111. (Pubitemid 28174692)
27. Matthias C, Bockmühl U, Jahnke V, Harries LW, Wolf CR, Jones PW, Alldersea J, Worrall SF, Hand P, Fryer AA, Strange RC. (1998). Te glutathione S-transferase GSTP1 polymorphism: Efects on susceptibility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics 8:1-6. (Pubitemid 28097595)
28. Matthias C, Bockmühl U, Jahnke V, Jones PW, Hayes JD, Alldersea J, Gilford J, Bailey L, Bath J, Worrall SF, Hand P, Fryer AA, Strange RC. (1998). Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: Studies in upper aerodigestive tract cancers. Pharmacogenetics 8:91-100. (Pubitemid 28227316)
29. McWilliams JE, Evans AJ, Beer TM, Andersen PE, Cohen JI, Everts EC, Henner WD. (2000). Genetic polymorphisms in head and neck cancer risk. Head Neck 22:609-617. (Pubitemid 30663077)
30. Mulder TP, Manni JJ, Roelofs HM, Peters WH, Wiersma A. (1995). Glutathione S-transferases and glutathione in human head and neck cancer. Carcinogenesis 16:619-624.
31. Nomura T, Noma H, Shibahara T, Yokoyama A, Muramatusu T, Ohmori T. (2000). Aldehyde dehydrogenase 2 and glutathione S-transferase M 1 polymorphisms in relation to the risk for oral cancer in Japanese drinkers. Oral Oncol 36:42-46.
32. Norppa H. (2004). Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 149:309-334. (Pubitemid 38469850)
33. Oude Ophuis MB, Roelofs HM, van den Brandt PA, Peters WH, Manni JJ. (2003). Polymorphisms of the glutathione S-transferase P1 gene and head and neck cancer susceptibility. Head Neck 25:37-43. (Pubitemid 36005329)
34. Park DJ, Lenz HJ. (2006). Determinants of chemosensitivity in gastric cancer. Curr Opin Pharmacol 6:337-344.
35. Park LY, Muscat JE, Kaur T, Schantz SP, Stern JC, Richie JP Jr, Lazarus P. (2000). Comparison of GSTM polymorphisms and risk for oral cancer between African-Americans and Caucasians. Pharmacogenetics 10:123-131. (Pubitemid 30193074)
36. Peters ES, McClean MD, Marsit CJ, Luckett B, Kelsey KT. (2006). Glutathione S-transferase polymorphisms and the synergy of alcohol and tobacco in oral, pharyngeal, and laryngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15:2196-2202. (Pubitemid 44877046)
37. Quiñones L, Lucas D, Godoy J, Cáceres D, Berthou F, Varela N, Lee K, Acevedo C, Martínez L, Aguilera AM, Gil L. (2001). CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. Te efect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Lett 174:35-44. (Pubitemid 33001306)
38. Ruwali M, Parmar D.(2010). Association of functionally important polymorphisms in cytochrome P450s with squamous cell carcinoma of head and neck. Indian J Exp Biol 48:651-665.
39. Saarikoski ST, Voho A, Reinikainen M, Anttila S, Karjalainen A, Malaveille C, Vainio H, Husgafvel-Pursiainen K, Hirvonen A. (1998). Combined efect of polymorphic GST genes on individual susceptibility to lung cancer. Int J Cancer 77:516-521. (Pubitemid 28340896)
40. Sabitha K, Reddy MVV, Jamil K. (2008). GST genotypes in head and neck cancer patients and its clinical implications. African J Biotechnology 7:3853-3859.
41. Sarikaya D, Bilgen C, Kamataki T, Topcu Z. (2006). Comparative cytochrome P450-1A1,-2A6,-2B6,-2C,-2D6,-2E1,-3A5 and-4B1 expressions in human larynx tissue analysed at mRNA level. Biopharm Drug Dispos 27:353-359. (Pubitemid 44842297)
42. Shiga H, Heath EI, Rasmussen AA, Trock B, Johnston PG, Forastiere AA, Langmacher M, Baylor A, Lee M, Cullen KJ. (1999). Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin Cancer Res 5:4097-4104. (Pubitemid 30013791)
43. Sikdar N, Mahmud SA, Paul RR, Roy B. (2003). Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett 195:33-42. (Pubitemid 36588976)
44. Singh M, Shah PP, Singh AP, Ruwali M, Mathur N, Pant MC, Parmar D. (2008). Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer. Mutat Res 638:184-194.
45. Soya SS, Vinod T, Reddy KS, Gopalakrishnan S, Adithan C. (2007). Genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) and upper aerodigestive tract cancer risk among smokers, tobacco chewers and alcoholics in an Indian population. Eur J Cancer 43:2698-2706. (Pubitemid 350151835)
46. Stoehlmacher J, Park DJ, Zhang W, Groshen S, Tsao-Wei DD, Yu MC, Lenz HJ. (2002). Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst 94:936-942. (Pubitemid 34778092)
47. Stoehlmacher J, Park DJ, Zhang W, Yang D, Groshen S, Zahedy S, Lenz HJ. (2004). A multivariate analysis of genomic polymorphisms: Prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer. Br J Cancer 91:344-354. (Pubitemid 39037082)
48. Tripathy CB, Roy N. (2006). Meta-analysis of glutathione S-transferase M1 genotype and risk toward head and neck cancer. Head Neck 28:217-224. (Pubitemid 43269888)
49. Tsuchida S, Sato K. (1992). Glutathione transferases and cancer. Crit Rev Biochem Mol Biol 27:337-384.
50. Vondracek M, Xi Z, Larsson P, Baker V, Mace K, Pfeifer A, Tjälve H, Donato MT, Gomez-Lechon MJ, Grafström RC. (2001). Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis 22:481-488. (Pubitemid 32203829)
51. Weijl NI, Cleton FJ, Osanto S. (1997). Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat Rev 23:209-240. (Pubitemid 27464149)
52. World Health Organization.(1979). WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland: WHO Publications Centre, Publication No. 48.
53. Zhang ZJ, Hao K, Shi R, Zhao G, Jiang GX, Song Y, Xu X, Ma J. (2011). Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer: A HuGE review and meta-analysis. Am J Epidemiol 173:847-857.